Uzm. Dr. Bilal Çağrı Bozdemir
Is this your profile? Claim it and verify your details.
Claim profileTrust
Where does this information come from?
The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.
- SpecialtyNuclear Medicinesaglik.gov.trFrom source
- InstitutionSivas Numune Hastanesisaglik.gov.trFrom source
- Publications5 publicationsORCID, Europe PMCFrom source
- ORCID0009-0006-3935-0018ORCIDFrom source
- Last synchronised5 November 2026 10:34https://sivasnumunedh.saglik.gov.tr/TR-767677/hekimlerimiz.html#bilal-cagri-bozdemirsaglik.gov.tr
Scientific work
Publications
-
Integrating Systemic Immune-Nutritional Indices with Anatomical Staging to Indicate Occult Bone Metastasis in Breast Cancer
Hitit Medical Journal, 2026
DOI 10.52827/hititmedj.2005868 Open-access full textSource: ORCID
-
Prognostic Value of PET-Based Metabolic Markers in Nivolumab-Treated NSCLC
Molecular Oncologic Imaging, 2025
DOI 10.71286/moi.1727407 Open-access full textSource: ORCID
-
An Innovative Approach with [68Ga]Ga-PSMA PET/CT: The Relationship Between PRIMARY Scores and Clinical and Histopathological Findings
Diagnostics, 2025
DOI 10.3390/diagnostics15141779 PMID 40722528 2 citations (Europe PMC) Open-access full textSource: ORCID
-
Radiation-induced Xerostomia: Evaluation with <sup>18</sup>F-FDG PET/CT
Molecular imaging and radionuclide therapy, 2025
DOI 10.4274/mirt.galenos.2025.04696 PMID 41058156 Open-access full textSource: Europe PMC
-
Predicting thyroid cancer ablation success: Pre-ablative 99mTc-Pertechnetate and post-ablative 131I scan comparison,Prédiction du succès de l'ablation dans le cancer de la thyroïde : une comparaison de la scintigraphie pré-ablative à la 99mTc-pertechnétate et de la scintigraphie post-ablative au 131I
Medecine Nucleaire, 2025
DOI 10.1016/j.mednuc.2024.05.001 Source: ORCID